The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global behavioral mental health care software market size reached US$ 2.82 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 6.37 Billion by 2027, exhibiting a growth rate (CAGR) of 13.30% during 2022-2027.
Behavioral mental healthcare software (BMHS) refers to a sophisticated and advanced custom-built solution that enables psychiatrists to communicate and monitor patient behavior trends to gain insights and track their condition. It has the potential to gather laboratory, radiology, and pharmacy-related data observations for providing comprehensive reports that examine the requirements of an individual. BMHS software further helps acquire electronic health records (EHR), perform health management practices, make clinical decisions, e-prescribing, and perform various administrative tasks. Along with this, it offers clinical decision support, allows online appointment scheduling through telehealth platforms, and maintains confidentiality regarding patient information, especially in case of substantial drug abuse. As a result, BMHS is used by community clinics and hospitals to enhance service providers efficiency by reducing treatment costs, provide value-based medicine programs, and diagnose various mental illnesses. Currently, BMHS is available in the cloud- or software-based deployment models.
The increasing prevalence of various psychological disorders, including anxiety, stress, paranoia, and depression, especially during the COVID-19 pandemic, and the rising focus of medical professionals on offering quality care have supplemented the demand for BMHS across the globe. Such technologies help behavioral health organizations in reducing treatment errors and paperwork, providing instant patient data access to ensure productivity, improving workflow, and mitigating healthcare costs, which is primarily driving the market growth. In line with this, favorable initiatives undertaken by governments to encourage the adoption of EHR and cognitive behavior therapies (CBT) to deal with mental disorders are acting as another growth-inducing factor. Additionally, the advent of automated BMHS to improve operational efficiencies by managing clinical, administrative, and financial tasks is propelling the market growth. Apart from this, considerable expansion in the healthcare infrastructure and ongoing research and development (R&D) activities to engineer advanced BMHS solutions are creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global behavioral mental health care software market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on solution, function, disorder type, delivery model and end use.
Breakup by Solution:
Breakup by Function:
Breakup by Disorder Type:
Breakup by Delivery Model:
Breakup by End Use:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Accumedic Computer Systems Inc., Advanced Data Systems, AdvancedMD Inc. (Global Payments Inc.), Compulink Healthcare Solutions, InSync Healthcare Solutions, Meditab Software Inc., Netsmart Technologies Inc., Psyquel, Qualifacts Systems LLC, Therapy Brands, TherapyNotes LLC, Valant Medical Solutions Inc. and Welligent Inc.
|Base Year of the Analysis||2021|
|Segment Coverage||Solution, Function, Disorder Type, Delivery Model, End Use, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Accumedic Computer Systems Inc., Advanced Data Systems, AdvancedMD Inc. (Global Payments Inc.), Compulink Healthcare Solutions, InSync Healthcare Solutions, Meditab Software Inc., Netsmart Technologies Inc., Psyquel, Qualifacts Systems LLC, Therapy Brands, TherapyNotes LLC, Valant Medical Solutions Inc. and Welligent Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Clinical Decision Support Systems (CDSS) Market by Component (Hardware, Software, Services), Product (Integrated CDSS, Standalone CDSS), Type (Therapeutic, Diagnostic), Delivery Mode (On Premise, Cloud Based), Model (Knowledge Based, Non-Knowledge Based), Application (Drug Allergy Alerts, Clinical Guidelines, Drug-Drug Interactions, Clinical Reminders, and Others), and Region 2023-2028
Blockchain in Healthcare Market by Network Type (Private, Public, and Others), Application (Supply Chain Management, Data Exchange and Interoperability, Claims Adjudication and Billing Management, and Others), End Use (Healthcare Providers, Healthcare Payers, Biopharmaceutical & Medical Device Companies, and Others), and Region 2023-2028
Disinfection Robots Market by Product Type (UV-Disinfection Robot, Hydrogen Peroxide Vaporization Robot (HPV), and Others), Technology (Fully Autonomous Disinfection Robots, Semi-Autonomous Disinfection Robots), End User (Hospitals and Clinics, Research Institutes, and Others), and Region 2023-2028
Remote Healthcare Market by Service (Remote Patient Monitoring, Real Time Virtual Health, Tele-ICU), Application (Diagnosis, Cardiology, Obstetrics, Senior Care, and Others), End User (Payer, Provider, Patient, Employer Groups and Government Organizations), and Region 2023-2028
Medication Management Market by Software (Computerized Physician Order Entry System, Clinical Decision Support System, Administration Software, Inventory Management System, Automated Dispensing Systems, Assurance System), Services (Medication Analytics Services, Point-Of-Care Verification Services, Adverse Drug Event (ADE) Surveillance Services), Mode of Delivery (Web-based, Cloud-based, On-premises), End User (Pharmacies, Hospitals and Others) and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at